Ginkgo Bioworks Holdings Market Sentiment

Market sentiment signals for Ginkgo Bioworks Holdings (DNA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▼ Sell

Short Interest▼ 13.6% short float

Options Flow▲ 0.57 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Sell

7 analysts

Options Flow (P/C)

0.57

More calls — Bullish

263 calls · 149 puts

Avg Consensus PT

$48

+308.5%

Highest Price Target

$120

+921.3%

TD Cowen

Lowest Price Target

-57.4%

BTIG

Short Interest

13.6%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 13, 2026	TD Cowen	Brendan Smith—	-6.4%	$9 → $11	Maintained	Hold
Sep 4, 2026	BTIG	Mark Massaro—	-57.4%	$5 → $5	Maintained	Sell
Aug 7, 2026	TD Cowen	Brendan Smith—	-23.4%	$12 → $9	Downgrade	Buy→Hold
Mar 12, 2026	BTIG	Mark Massaro—	-57.4%	$9 → $5	Maintained	Sell
Jan 8, 2026	TD Cowen	Brendan Smith—	+2.1%	$14 → $12	Maintained	Buy
Aug 25, 2025	BTIG	Mark Massaro—	-23.4%	$6 → $9	Maintained	Sell
Sep 20, 2024	TD Cowen	Brendan Smith—	-14.9%	$3 → $10	Maintained	Buy
Aug 23, 2024	BTIG	Mark Massaro—	-40.4%	$0 → $7	Maintained	Sell
Jul 9, 2024	Goldman Sachs	Matthew Sykes—	-97.4%	$1 → $0	Maintained	Sell
Jun 26, 2024	BTIG	Mark Massaro—	-98.3%	$1 → $0	Maintained	Sell
May 15, 2024	BTIG	Mark Massaro—	—	—	Downgrade	Neutral→Sell
May 15, 2024	Morgan Stanley	Tejas Savant—	-91.5%	$2 → $1	Maintained	Equal-Weight
May 10, 2024	William Blair	Matt Larew—	—	—	Downgrade	Market Perform→Underperform
Mar 1, 2024	TD Cowen	Steven Mah—	-74.5%	$7 → $3	Maintained	Outperform
Jan 23, 2024	Goldman Sachs	Matthew Sykes—	-90.6%	$1 → $1	Maintained	Sell
Jan 22, 2024	Goldman Sachs	Matthew Sykes—	-90.6%	$1 → $1	Maintained	Sell
Nov 15, 2023	Raymond James	Rahul Sarugaser—	-78.7%	$3	Downgrade	Outperform→Market Perform
Nov 14, 2023	Raymond James	Rahul Sarugaser—	-78.7%	$3	Downgrade	Outperform→Market Perform
Nov 9, 2023	BTIG	Mark Massaro—	—	—	Downgrade	Buy→Neutral